FORMAN, WALTER B., MD

EDUCATION

B.A., 1960, Wayne State University
M.D. (Medicine) 1963, Wayne State University

PROFESSIONAL CERTIFICATION
Licensed Physician, States of New Mexico, Michigan, Ohio

EMPLOYMENT

2007 - Present	Investigator, Lovelace Scientific Resources, Albuquerque, NM
2005 - 2007	Medical Director, Heritage Hospice and Home Care, Albuquerque, NM
2004 - 2007	Medical Director, Laguna Nursing Home
1996 - Present	Professor, University of New Mexico Health Sciences Center, Albuquerque, NM
1992 - 1996	Associate Chief of Staff, New Mexico Regional Federal Medical Center, Albuquerque, NM
1988 - 1992	Staff Physician, Geriatrics, Hematology/Oncology New Mexico Regional Federal Medical Center, University of New Mexico Cancer Center, Albuquerque, NM
1988 - 1995	Associate Professor, Dept. of Medicine, University of New Mexico School of Medicine, Albuquerque, NM
1988	Acting Medical Director, Catholic Hospice Network, Cleveland, OH
1985 - 1988	Staff Physician and Director Hematology/Oncology, St. John’s Hospital, Cleveland, OH
1982 - 1988	Director, Cancer Center And the Div. Hematology/Oncology, Saint Vincent Charity Hospital, Cleveland, OH
1982 - 1988	Associate Clinical Professor, Dept. of Medicine, Case Western University, School of Medicine, Cleveland, OH
1981 - 1984	Chairman Hematology/Oncology Committee Case, Western Reserve University School of Medicine, Cleveland, OH
1979 - 1982	Assoc. Prof. Tenured, Dept. of Med., Case Western University, School of Medicine, Cleveland, OH
1974 - 1988	Staff Physician, University Hospitals of Cleveland, Cleveland, OH
1971 - 1982	Chief, Hematology/Oncology Section, Veterans Administration Medical Center, Cleveland, OH
1971 - 1979	Asst. Prof., Depts. Of Medicine and Pharmacology, Cast Western Reserve University, School of Medicine, Cleveland, OH
1969 - 1988	Staff Physician, Menorah Park Home for the Aged, Cleveland, OH
1969 - 1971	U.S. Public Health Service Fellow, Dept. of Medicine and Pharmacology, Case Western Reserve University, Cleveland, OH
1967 - 1969	Chief, Department of Medicine, United States Air Force, Lockbourne Air Force Base, Columbus, OH
1966 - 1967	Research Fellow, American Heart Association, University of Cleveland, OH
1965 - 1966	Senior Assistant Resident in Medicine, Cleveland Metropolitan General Hospital, Cleveland, OH
1964 - 1965	Assistant Resident in Medicine, Cleveland Metropolitan General Hospital, Cleveland, OH
1963 - 1964	Straight Pediatric Intern, Cleveland Metropolitan General Hospital, Cleveland, OH

PROFESSIONAL AFFILIATIONS
New Mexico Cancer Pain Initiative
New Mexico Cancer Information Service Advisory Committee
American Cancer Society, National Committee for Cancer Pain Relief

REPRESENTATIVE RESEARCH PROJECTS

A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of (study drug) in Subjects with Essential Hypertension, 2007.
Open-Label Extension, Single-Arm, Flexible-Dosing, Phase III Trial with (study drug) Extended-Release (ER) in Subjects with Moderate to Severe Chronic Pain, 2007.
A Multicenter Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of (study drug) in Moderately Obese Hyperlipidemic Patients With or Without Concomitant Atorvastatin, 2007.
A Randomized, Double-Blind Placebo-Controlled Dose Escalation Study of (study drug)100 and 200 mg Daily in Patients with Fibromyalgia: Effects on 24-Hour Ambulatory Blood Pressure Monitoring, 2007.
A Multicenter, Randomized, Double Blind, Placebo Controlled Study Comparing the Safety and Efficacy of (study drug) Sustained Release (SR)/Bupropion Sustained Release (SR) and Placebo in Obese Subjects, 2007.
A Multinational, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel Group Efficacy and Safety Comparison over 24 Weeks of Three Doses (50 mg, 100 mg, 200 mg) of (study drug) to Tiotropium 5 mg and Placebo Delivered by the Respimat® Inhaler in Patients with Chronic Obstructive Pulmonary Disease (COPD), 2007.
A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial of (study drug) in Adults with Primary Insomnia, 2007.
A 2-Month Safety Follow-up Trial of Subjects from Mannkind Protocols, 2007.
A Randomized, Double-Blind, Double-Dummy Placebo-Controlled, Crossover Study to Evaluate the Efficacy of (study drug) versus (study drug) for the Acute Treatment of Migraine when Administered During the Moderate-Severe Pain Phase of Migraine, 2008.
A 16-Week, Phase 1, Multicenter, Double-Blind, Randomized, (study drug) Controlled, Parallel-Group Pharmacological Study, to Assess the Effect of (study drug) (375 mg and 750 mg, bid) compared to equimolar doses of (study drug) (250 mg and 500 mg, bid) and to (study drug) (600 mg, tid) on Arterial Blood Pressure as Measured by Ambulatory Blood Pressure Monitoring in Osteoarthritis Patients with Controlled Essential Hypertension, 2008.
A 24-Week (+ 24 week extension), Randomised, Placebo-Controlled (only 1st 12-week period), Double-Blind, Parallel-Group, Efficacy and Safety Comparison of (study drug) (7.5 mg/25 mg) Inhalation Powder in the Morning (PE capsule via tiotropium/salmeterol HandiHaler®), (study drug) (18 mg) Inhalation Powder in the Morning (gelatine capsule via Spiriva® HandiHaler®), (study drug) (25 mg) Powder in the Morning and Evening (PE capsule via tiotropium/salmeterol HandiHaler®) and (study drug) (7.5 mg/25 mg) Inhalation Powder in the Morning (PE capsule via (study drug) HandiHaler®) plus (study drug) (25 mg) Inhalation Powder in the Evening (PE capsule via (study drug) HandiHaler®) in Patients with COPD, 2008.
A Randomized, Double-Blind, Placebo-Controlled, Double-Dummy, Parallel-Group, Multicenter, Dose-Ranging Study in Subjects With Type 2 Diabetes Mellitus to Evaluate the Efficacy, Safety, and Tolerability of Orally-Administered (study drug) with (study drug) as a Reference Arm IND, 2008.
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment with (study drug) 20 mg qd to Placebo qd in Patients with Heartburn and Sleep Disturbances Associated with Gastroesophageal Reflux Disease (GERD), 2008.
A Dose-Response Study of (study drug) Compared with Concurrent Placebo Control and Lyrica (pregabalin), in Subjects with Neuropathic Pain Associated with Diabetic Peripheral Neuropathy (DPN), 2008.
An Efficacy and Safety Study of (study drug) Compared with a Concurrent Placebo Control in Subjects with Neuropathic Pain Associated with Post-Herpetic Neuralgia (PHN), 2008.